Abstract
SummaryTwenty cases of American Cutaneous leishmaniasis were treated with intramuscular injection of 2.5 ml cycloguanil pamoate (Camolar®). Improvement was observed in all cases, and complete clinical and parasitologic cure was obtained in 16 (80%), although the healing response was often delayed, and viable parasites were demonstrated up to 15 weeks after injection of the drug. Second injections were necessary in nine patients, and one received a third injection. In three of the four failures of treatment there had been prior unsuccessful treatment with other drugs. No adverse reactions to the drug were encountered, and cycloguanil pamoate effected dramatic reduction in lost-duty time and hospital costs compared with patients treated with antimonials.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The American journal of tropical medicine and hygiene
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
